Jessica I. Lundin

Jessica I. Lundin

Auto-generated profile, based on publicly available information

Jessica I. Lundin

Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2022 in Environmental Science & Technology
Verified
Journal Article
Closed access
KPKatherine Peter
Katherine Peter
JLJessica I. Lundin
Jessica I. Lundin
CWChristopher Wu
Christopher Wu
BFBlake E. Feist
Blake E. Feist
ZTZhenyu Tian
Zhenyu Tian
EKEdward P. Kolodziej
Edward P. Kolodziej

22 March 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JLJessica I Lundin
Jessica I Lundin
JSJulann A Spromberg
Julann A Spromberg
JJJeffrey C Jorgensen
Jeffrey C Jorgensen
JMJames M Myers
James M Myers
PCPaul M Chittaro
Paul M Chittaro
NSNathaniel L Scholz
Nathaniel L Scholz
In the western United States, the long-term recovery of many Pacific salmon populations is inextricably linked to freshwater habitat quality. Industrial activities from the past century have left a legacy of pollutants that persist, particularly near working waterfronts. The adverse impacts of these contaminants on salmon health have been studied for decades, but the population-scale consequences of chemical exposure for salmonids are still poorly understood. We estimated acute and delayed mortality rates for seaward migrating juvenile Chinook salmon that feed and grow in a Superfund-designated area in the Lower Willamette River in Portland, Oregon. We combined previous, field-collected exposure data for juvenile Chinook salmon together with reduced growth and disease resistance data from earlier field and laboratory studies. Estimates of mortality were then incorporated into a life cycle model to explore chemical habitat-related fish loss. We found that 54% improved juvenile survival—potentially as a result of future remediation activities—could increase adult Chinook salmon population abundance by more than 20%. This study provides a framework for evaluating pollution remediation as a positive driver for species recovery.

20 May 2025 in Atherosclerosis
Verified
Journal Article
Open access
JLJessica I. Lundin
Jessica I. Lundin
UPUlrike Peters
Ulrike Peters
YHYao Hu
Yao Hu
FAFarah Ammous
Farah Ammous
Emelia J. BenjaminEmelia J. Benjamin
Emelia J. Benjamin
CKCharles Kooperberg
Charles Kooperberg
Cardiovascular disease (CVD) is one of the leading causes of morbidity and mortality worldwide, yet the underlying molecular mechanisms remain less understood. Chronic low-grade inflammation is a complex immune response contributing to the pathophysiology of cardiovascular disease. This response is signaled in part by interleukin-6 (IL-6), a pleiotropic, pro-inflammatory cytokine. Phenotypic variance in circulating IL-6 level may be explained in part by DNA methylation which is increasingly being associated with cardiovascular effects. In this study we evaluated methylated DNA (CpG sites) associated with blood IL-6 levels across ∼4,400 ancestrally diverse individuals (81 % self-reported White; 9 % Black or African American, 8 % Hispanic or Latino/a, and 2 % Chinese American). We identified 178 CpG sites associated with IL-6 (p<0.05/∼395,000). Among the sites, cg04437762 is located within the transcription unit of IL6R, a current therapeutic target for inflammatory disease, and cg26692003 and cg00464927 were significant for IL6 and IL6ST trans-CpG-gene transcripts. Functional gene expression downstream of methylation identified cellular response to IL-6 and B-cell regulation and activation pathways. Four genes were linked with both a genetic component of cardiovascular disease and an IL-6 associated CpG site. Three CpG sites identified through Mendelian randomization analyses supported inference of a causal effect on IL-6 levels, including the LYN gene that regulates immune cell signaling and has been previously associated with atherosclerosis. Overall, we identified several novel IL-6-CpG sites and downstream pathways affected by methylation. Follow-up functional studies including the regulation of IL-6 would complement current knowledge of CVD pathophysiology and potential therapeutic targets.

12 July 2021 in Environmental Science & Technology
Verified
Journal Article
Open access
JLJessica I. Lundin
Jessica I. Lundin
PCPaul M. Chittaro
Paul M. Chittaro
GYGina M. Ylitalo
Gina M. Ylitalo
JKJohn W. Kern
John W. Kern
DKDavid R. Kuligowski
David R. Kuligowski
NSNathaniel L. Scholz
Nathaniel L. Scholz
The industrial waterway in Portland Harbor, Oregon, is a migration corridor for a distinct population segment of Chinook Salmon (Upper Willamette River) currently protected by the U.S. Endangered Species Act. Juveniles are exposed to a suite of contaminants during outmigration including polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and dichlorodiphenyltrichloroethanes. We collected natural origin subyearling Chinook salmon from sites in and around the industrial harbor to evaluate growth (otolith microstructural analysis) in relation to measured chemical concentrations in tissue. A reduced growth rate was associated with higher tissue contaminant concentrations, particularly mixtures represented by PAHs and certain PCBs, which were elevated in juvenile Chinook collected throughout sites within Portland Harbor relative to those captured upstream. First-year growth is an established predictor of individual survival and eventual reproductive success in Chinook salmon. Therefore, our results indicate that legacy pollution may be limiting the population abundance of threatened Willamette River Chinook salmon, and future habitat remediation or restoration actions may benefit ongoing species recovery efforts.

3 April 2024 in Epigenetics
Verified
Journal Article
Open access
JLJessica I. Lundin
Jessica I. Lundin
UPUlrike Peters
Ulrike Peters
YHYao Hu
Yao Hu
FAFarah Ammous
Farah Ammous
CAChristy L. Avery
Christy L. Avery
OSOn Behalf of the PAGE Study
On Behalf of the PAGE Study
Systemic low-grade inflammation is a feature of chronic disease. C-reactive protein (CRP) is a common biomarker of inflammation and used as an indicator of disease risk; however, the role of inflammation in disease is not completely understood. Methylation is an epigenetic modification in the DNA which plays a pivotal role in gene expression. In this study we evaluated differential DNA methylation patterns associated with blood CRP level to elucidate biological pathways and genetic regulatory mechanisms to improve the understanding of chronic inflammation. The racially and ethnically diverse participants in this study were included as 50% White, 41% Black or African American, 7% Hispanic or Latino/a, and 2% Native Hawaiian, Asian American, American Indian, or Alaska Native (total n = 13,433) individuals. We replicated 113 CpG sites from 87 unique loci, of which five were novel (CADM3, NALCN, NLRC5, ZNF792, and cg03282312), across a discovery set of 1,150 CpG sites associated with CRP level (p < 1.2E-7). The downstream pathways affected by DNA methylation included the identification of IFI16 and IRF7 CpG-gene transcript pairs which contributed to the innate immune response gene enrichment pathway along with NLRC5, NOD2, and AIM2. Gene enrichment analysis also identified the nuclear factor-kappaB transcription pathway. Using two-sample Mendelian randomization (MR) we inferred methylation at three CpG sites as causal for CRP levels using both White and Black or African American MR instrument variables. Overall, we identified novel CpG sites and gene transcripts that could be valuable in understanding the specific cellular processes and pathogenic mechanisms involved in inflammation.

15 May 2024
Verified
Journal Article
Closed access
MJMin-Zhi Jiang
Min-Zhi Jiang
SGSheila M. Gaynor
Sheila M. Gaynor
XLXihao Li
Xihao Li
EBEric Van Buren
Eric Van Buren
ASAdrienne Stilp
Adrienne Stilp
LRLaura M. Raffield
Laura M. Raffield